Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 11 | 2025 | 174 | 6.160 |
Why?
|
| Anticoagulants | 5 | 2025 | 496 | 1.950 |
Why?
|
| Emergency Service, Hospital | 23 | 2024 | 1105 | 1.900 |
Why?
|
| Outpatients | 2 | 2023 | 138 | 1.370 |
Why?
|
| Noninvasive Ventilation | 2 | 2020 | 69 | 1.260 |
Why?
|
| Opioid-Related Disorders | 4 | 2024 | 509 | 1.140 |
Why?
|
| Heparin, Low-Molecular-Weight | 2 | 2025 | 25 | 1.090 |
Why?
|
| Decision Support Systems, Clinical | 2 | 2024 | 72 | 1.000 |
Why?
|
| Physicians | 2 | 2022 | 475 | 0.970 |
Why?
|
| Qualitative Research | 4 | 2025 | 698 | 0.960 |
Why?
|
| Hospitalization | 4 | 2025 | 1362 | 0.880 |
Why?
|
| Emergency Medicine | 4 | 2024 | 190 | 0.860 |
Why?
|
| Cannula | 2 | 2020 | 24 | 0.850 |
Why?
|
| Harm Reduction | 1 | 2024 | 33 | 0.820 |
Why?
|
| Restraint, Physical | 1 | 2023 | 41 | 0.790 |
Why?
|
| Humans | 48 | 2025 | 63608 | 0.760 |
Why?
|
| Transsexualism | 1 | 2022 | 15 | 0.750 |
Why?
|
| Buprenorphine | 2 | 2022 | 193 | 0.720 |
Why?
|
| Transgender Persons | 1 | 2022 | 69 | 0.690 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 77 | 0.670 |
Why?
|
| Emergency Medical Services | 2 | 2023 | 271 | 0.670 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 148 | 0.660 |
Why?
|
| Electric Countershock | 2 | 2020 | 102 | 0.640 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2025 | 710 | 0.620 |
Why?
|
| Periodicals as Topic | 1 | 2022 | 175 | 0.620 |
Why?
|
| Patient Discharge | 1 | 2023 | 512 | 0.620 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 96 | 0.610 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1557 | 0.610 |
Why?
|
| Occupational Diseases | 1 | 2020 | 267 | 0.570 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.560 |
Why?
|
| Patient Safety | 1 | 2020 | 244 | 0.560 |
Why?
|
| Coronavirus Infections | 2 | 2021 | 209 | 0.560 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 297 | 0.530 |
Why?
|
| Patient Care Team | 1 | 2020 | 341 | 0.530 |
Why?
|
| Retrospective Studies | 10 | 2024 | 6694 | 0.520 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 223 | 0.520 |
Why?
|
| Health Personnel | 1 | 2020 | 370 | 0.510 |
Why?
|
| Spinal Puncture | 1 | 2016 | 16 | 0.500 |
Why?
|
| Headache | 1 | 2016 | 58 | 0.490 |
Why?
|
| Rivaroxaban | 1 | 2015 | 19 | 0.480 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 115 | 0.440 |
Why?
|
| Analgesics | 1 | 2015 | 102 | 0.440 |
Why?
|
| Pain Management | 2 | 2021 | 163 | 0.430 |
Why?
|
| Heparin | 2 | 2025 | 116 | 0.410 |
Why?
|
| Social Media | 3 | 2022 | 127 | 0.410 |
Why?
|
| Patient Satisfaction | 2 | 2020 | 436 | 0.400 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 90 | 0.380 |
Why?
|
| Analgesia | 2 | 2022 | 31 | 0.360 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 838 | 0.360 |
Why?
|
| Acute Disease | 2 | 2024 | 672 | 0.340 |
Why?
|
| Female | 11 | 2025 | 33000 | 0.310 |
Why?
|
| Adult | 12 | 2025 | 16894 | 0.310 |
Why?
|
| United States | 8 | 2024 | 7863 | 0.310 |
Why?
|
| Male | 10 | 2025 | 29988 | 0.310 |
Why?
|
| Policy | 3 | 2024 | 56 | 0.300 |
Why?
|
| Intubation, Intratracheal | 2 | 2020 | 203 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 1648 | 0.240 |
Why?
|
| Middle Aged | 6 | 2025 | 17702 | 0.230 |
Why?
|
| Naloxone | 1 | 2024 | 61 | 0.200 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2024 | 113 | 0.200 |
Why?
|
| Seizures | 1 | 2024 | 143 | 0.200 |
Why?
|
| Shoulder Dislocation | 1 | 2022 | 9 | 0.200 |
Why?
|
| Aged | 7 | 2024 | 14512 | 0.200 |
Why?
|
| Brain Concussion | 1 | 2023 | 35 | 0.190 |
Why?
|
| Point-of-Care Testing | 1 | 2023 | 43 | 0.190 |
Why?
|
| Fibrinolytic Agents | 1 | 2024 | 170 | 0.190 |
Why?
|
| Fear | 1 | 2023 | 70 | 0.190 |
Why?
|
| Guideline Adherence | 1 | 2025 | 305 | 0.190 |
Why?
|
| Anesthesia | 1 | 2022 | 50 | 0.190 |
Why?
|
| Appendicitis | 1 | 2023 | 82 | 0.190 |
Why?
|
| Blood Transfusion | 1 | 2023 | 162 | 0.180 |
Why?
|
| Gender Identity | 1 | 2022 | 68 | 0.180 |
Why?
|
| Nurses | 1 | 2023 | 109 | 0.180 |
Why?
|
| Methoxyflurane | 1 | 2021 | 1 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2024 | 536 | 0.180 |
Why?
|
| Brain Injuries | 1 | 2023 | 140 | 0.180 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2021 | 9 | 0.180 |
Why?
|
| Point-of-Care Systems | 1 | 2023 | 131 | 0.170 |
Why?
|
| Ureterolithiasis | 1 | 2021 | 14 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 50 | 0.170 |
Why?
|
| Accidental Falls | 1 | 2022 | 127 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2023 | 311 | 0.170 |
Why?
|
| Abscess | 1 | 2021 | 80 | 0.160 |
Why?
|
| Wounds and Injuries | 1 | 2023 | 248 | 0.160 |
Why?
|
| Recurrence | 1 | 2022 | 642 | 0.160 |
Why?
|
| Drainage | 1 | 2021 | 154 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2020 | 107 | 0.160 |
Why?
|
| Comorbidity | 1 | 2023 | 1119 | 0.160 |
Why?
|
| Accountable Care Organizations | 1 | 2020 | 67 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 197 | 0.150 |
Why?
|
| Drug Overdose | 1 | 2020 | 131 | 0.140 |
Why?
|
| Occupational Exposure | 1 | 2020 | 315 | 0.140 |
Why?
|
| Coma | 1 | 2017 | 13 | 0.130 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 40 | 0.130 |
Why?
|
| Cultural Diversity | 1 | 2017 | 54 | 0.130 |
Why?
|
| Resuscitation | 1 | 2017 | 73 | 0.130 |
Why?
|
| Medicare | 1 | 2020 | 613 | 0.120 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 5496 | 0.120 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 56 | 0.120 |
Why?
|
| Asthma | 1 | 2020 | 460 | 0.120 |
Why?
|
| Head | 1 | 2016 | 54 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2017 | 198 | 0.120 |
Why?
|
| Acute Kidney Injury | 1 | 2017 | 141 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 672 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2023 | 810 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 764 | 0.110 |
Why?
|
| Contrast Media | 1 | 2017 | 426 | 0.110 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 108 | 0.110 |
Why?
|
| Massachusetts | 1 | 2020 | 2075 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 790 | 0.110 |
Why?
|
| Data Collection | 1 | 2015 | 384 | 0.100 |
Why?
|
| Child | 1 | 2023 | 4535 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 981 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2020 | 2081 | 0.100 |
Why?
|
| Internet | 1 | 2015 | 470 | 0.090 |
Why?
|
| Electrocardiography | 2 | 2024 | 552 | 0.080 |
Why?
|
| Communication | 2 | 2023 | 579 | 0.070 |
Why?
|
| Odds Ratio | 2 | 2017 | 768 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 890 | 0.060 |
Why?
|
| Computers | 1 | 2024 | 49 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2024 | 104 | 0.050 |
Why?
|
| Chest Pain | 1 | 2024 | 84 | 0.050 |
Why?
|
| Lidocaine | 1 | 2022 | 33 | 0.050 |
Why?
|
| Conscious Sedation | 1 | 2022 | 39 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2024 | 193 | 0.050 |
Why?
|
| Workflow | 1 | 2023 | 71 | 0.050 |
Why?
|
| Research | 1 | 2024 | 195 | 0.050 |
Why?
|
| Triage | 1 | 2024 | 129 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 71 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2023 | 125 | 0.050 |
Why?
|
| Documentation | 1 | 2023 | 128 | 0.050 |
Why?
|
| Heart Rate | 1 | 2023 | 322 | 0.040 |
Why?
|
| Bandages | 1 | 2021 | 15 | 0.040 |
Why?
|
| Methadone | 1 | 2022 | 134 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2022 | 163 | 0.040 |
Why?
|
| Decision Trees | 1 | 2021 | 51 | 0.040 |
Why?
|
| Fever | 1 | 2021 | 66 | 0.040 |
Why?
|
| Hospitals | 1 | 2024 | 394 | 0.040 |
Why?
|
| Uncertainty | 1 | 2020 | 37 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2023 | 485 | 0.040 |
Why?
|
| Software | 1 | 2023 | 387 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2024 | 5703 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 353 | 0.040 |
Why?
|
| Opiate Substitution Treatment | 1 | 2022 | 207 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2023 | 364 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 305 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 1667 | 0.040 |
Why?
|
| Cough | 1 | 2021 | 183 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 571 | 0.040 |
Why?
|
| Algorithms | 1 | 2023 | 1005 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 407 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 873 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2017 | 20 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 40 | 0.030 |
Why?
|
| Renal Replacement Therapy | 1 | 2017 | 24 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 61 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 64 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 53 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 5365 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 254 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 775 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 418 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 3304 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1384 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 167 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2017 | 288 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 694 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 938 | 0.030 |
Why?
|
| Patient Selection | 1 | 2017 | 490 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1277 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 879 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4711 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2586 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6257 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3768 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2699 | 0.020 |
Why?
|